Skip to content
zameds

Pantoprazole (Adco Pantoprazole, Pantoprazole Propan)

Pantoprazole

Adcock ingram limited

Every registration of this product has been cancelled.

Registration

Applicant
Adcock ingram limited
Registrations
4

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Adco pantoprazole 20

EACH TABLET CONTAINS PANTOPRAZOLE 20,0 mg

2048122848/11.4.3/1228CancelledNot determinedNone
Adco pantoprazole 40

EACH TABLET CONTAINS PANTOPRAZOLE 40,0 mg

4048122948/11.4.3/1229CancelledNot determinedNone
Pantoprazole propan 20

EACH TABLET CONTAINS PANTOPRAZOLE 20,0 mg

2048123048/11.4.3/1230CancelledNot determinedNone
Pantoprazole propan 40

EACH TABLET CONTAINS PANTOPRAZOLE 40,0 mg

4048123148/11.4.3/1231CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S4: Pantoprazole

    • except when intended for the temporary short-term relief of heartburn and hyperacidity, subject to:
    • a maximum daily dose of 20 milligrams (S2); and
    • a maximum treatment period of 14 days. (S2)

    Consolidated Schedules 06 July 2026, lines 7479 to 7482

  • S2: Pantoprazole

    • when intended for the temporary short-term relief of heartburn and hyperacidity, subject to:
    • maximum daily dose of 20 milligrams
    • maximum treatment period of 14 days. (S4)

    Consolidated Schedules 06 July 2026, lines 2482 to 2486

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C16H15F2N3O4S383.40 g/mol

6-(Difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridinyl)methylsulfinyl]-1H-benzimidazole

Drag to rotate. Structure from PubChem CID 4679.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles